Numbers

Claude View

The Numbers

NOMD trades at ~$9.67 — a multi-year low and roughly half the price of a year ago — because the market has decided a low-growth, high-leverage European frozen food platform with structurally mid-single-digit operating margins is worth only ~6x EBITDA and ~8.7x earnings. The single metric that reprices this stock is free cash flow durability: a ~21% FCF yield and a ~25% total cash-return yield (dividend + buyback) only work if EBITDA stabilises. The 2025 volume miss and the resulting interest-coverage compression to ~2.2x are the derating engine.

Critical chart: the de-rating of NOMD is not a multiple story — it is an earnings story. Net income fell from $237M in FY2024 to $161M in FY2025 while debt rose, collapsing interest coverage and forcing the market to re-underwrite the dividend and buyback pace.

Price + valuation snapshot

Price (USD)

$9.67

Market Cap ($M)

$1,401

Enterprise Value ($M)

$3,715

Trailing P/E

8.7

EV / EBITDA

6.2

FCF Yield

21.1%

Dividend Yield

7.7%

Total Cash-Return Yield

24.7%

Two step-downs define the chart: an August 2025 break from the ~$17 base to ~$15 on Q2 volume/revenue softness, and a February-March 2026 capitulation from ~$13 to under $10 as the FY2025 results confirmed a revenue miss and margin compression. The stock has essentially lost half its value in twelve months without a single obvious catalyst — a classic slow-motion de-rating.

Revenue & earnings power

Revenue optically grew 10% in FY2025 in USD, but Nomad reports in EUR and the underlying EUR figure was down ~2% (EUR 3,032M vs EUR 3,099M in FY2024, per the 6-K). The story the market is reacting to is the EUR story, not the USD one — flat-to-declining organic volume in a category that should be defensive.

FY2025 revenue came in at EUR 3,032M vs a consensus estimate near EUR 3,570M — a **meaningful miss** — and net income fell **~40% YoY in EUR**. That is the proximate cause of the Feb–Mar 2026 drawdown.

Gross margin fell ~250 bps in FY2025 and net margin halved from 7.3% to 4.5%. Operating income is essentially flat in USD terms, but interest expense nearly doubled (from $114M to $212M) which is what crushed reported profit.

Cash generation & capital allocation

Cash generation is real but declining: FCF slipped from $387M (FY2023) to $297M (FY2025), a ~23% fall over two years. Capex is light (~2.6% of sales), so the compression is almost entirely working-capital and lower EBITDA, not reinvestment.

Nomad initiated a dividend in 2024 and has aggressively repurchased stock: $238M of buybacks in FY2025 plus $107M of dividends — together ~$345M, which is 116% of FCF and explains why net debt is rising despite positive FCF.

Buybacks + dividends exceeded FCF by ~$48M in FY2025. That pace is not sustainable alongside rising leverage — **something has to give**: either the buyback slows, FCF re-accelerates, or leverage creeps higher. This is the #1 quant question into FY2026.

Share count is down ~12% over two years — aggressive for a staples name. At the current ~$9.67 and an $500M authorisation outstanding, continued repurchases could retire another 5-10% of the float if management chooses to lean in.

Balance sheet & leverage

Net debt re-expanded by ~$466M in FY2025 (from $1,848M to $2,314M) — driven by buybacks, dividends and an acquisition tuck-in (Findus/assets). Book equity is optically $2.9B but $5.4B of that sits in goodwill, implying tangible book is deeply negative.

Interest coverage halved in one year — from 4.2x to 2.2x — as interest expense jumped from $114M to $212M on refinanced term loans and higher European rates. This is the single number most likely to force management to slow capital returns.

Net Debt 2025 ($M)

$1,913

Interest Coverage 2025

4.8

EV / EBITDA

6.2

Peer comparison

No Results

The peer screen is unforgiving: NOMD is the smallest name, has the lowest ROIC (5.8%), the thinnest gross margin (27%), yet screens as cheap on EV/EBITDA and cheapest on P/S. GIS is the clear quality leader. CPB is the only peer with a genuinely similar EV/EBITDA (4.2x) but it has a fortress balance sheet (D/E 0.11) — a structural reason NOMD trades at a discount.

NOMD sits in the "low margin, low multiple" quadrant near CPB. The path to rerating to GIS-like multiples requires margin expansion that the current organic trajectory does not support.

What the market is pricing

At a ~21% FCF yield and ~25% total cash-return yield, the market is pricing either (a) a permanent step-down in cash flow, or (b) forced buyback cut to service leverage. If neither materialises and FY2026 EBITDA stabilises, the equity has asymmetric upside to a 10x P/E.

Bottom line

The numbers confirm: NOMD is a cash-generative, structurally lower-margin European frozen food platform whose share price has halved primarily on a 40% drop in reported net income (EUR basis), a doubling of interest expense, and a volume-led revenue miss in FY2025.

The numbers contradict: the "value trap" narrative — FCF was still $297M, the business bought back $238M and paid $107M of dividends, and the float is 12% smaller than two years ago. Buybacks above FCF are only sustainable for another year.

What must be watched next quarter (Q1 FY2026): (1) EUR organic revenue growth — the swing from -2% to positive is the rerate trigger; (2) gross margin — recovery above 28% would flag input-cost relief; (3) interest expense run-rate — if it stabilises near $210M the coverage ratio stops falling; (4) buyback pace — any pause signals management acknowledging the leverage constraint.